Our main focus: Common diseases such as asthma, allergies and chronic obstructive pulmonary disease (COPD), as well as infection-related inflammation of the lungs, in particular tuberculosis (TB).
04.02.2025
Prof. Torsten Goldmann and his team from the “Histology” are investigating the TGF-beta signaling pathway in lung cancer as a new therapeutic target in a project funded by the German Centre for Lung Research (DZL).
03.02.2025
Borstel, 03.02.2025 – A team of researchers led by Dr. Maja Reimann at the Research Center Borstel, Leibniz Lung Center, has developed an RNA-based biomarker that can monitor treatment response in tuberculosis (TB) without bacterial culture.
30.01.2025
Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible. Researchers from the Marius Nasta Institute (MNI) and the Research Center Borstel, Leibniz Lung Center (FZB) have now evaluated a new test for the early detection of changes in the bacterial load o